Skip to main content

Table 2 Timing of visits and data collection (SPIRIT)

From: Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial

 

Visits/time points

1

2

3

4

5

6

Procedures

Screening

Baseline

Follow-up

 

Maximum 42 days

Week 0

Week 4

Week 12

Week 24

Week 28

Informed consent

x

     

Inclusion/exclusion

x

x

x

x

x

 

Demographics

x

     

Medical history

x

     

Concomitant medication

x

x

x

x

x

 

Hand pain 0–10 NRS

x

x

x

x

x

 

Pain manikin

 

x

 

x

x

 

Physical examination

x

 

x

x

x

 

Vital signs

x

 

x

x

x

 

Blood screening

x

     

Urine dipstick

x

Xa

Xa

Xa

Xa

 

Urine pregnancy test

Xa

Xa

Xa

Xa

Xa

 

Bilateral hand X-ray (if applicable)

x

     

Hand pain rating (remote)

Training

x

x

x

x

 

Randomisation

 

x

    

Prescription/dispensing

 

x

 

x

  

Reported study medication compliance

  

x

x

x

 

Advice on barrier contraception

 

Xa

Xa

Xa

Xa

 

Joint count

 

x

 

x

x

 

Questionnaires

 

x

 

x

x

 

Photographs of swollen hand joints

 

x

 

x

x

 

Grip strength

 

x

 

x

x

 

Safety blood monitoring c

  

x

x

x

 

Safety/adverse events

  

x

x

x

x

Advice on weaning off study medication

    

x

 

Bang’s Blinding Index

    

x

 

End of treatment questionnaire

    

x

 

Focus groupb (optional)

 
  1. aAt discretion of investigator
  2. bAfter last participant has completed visit 6
  3. cIncludes creatinine, urea and electrolytes, liver function, full blood count and C-reactive protein